NeuroOne Medical Technologies Corporation
NMTC
$0.567
-$0.0126-2.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.19M | -12.32M | -12.10M | -12.80M | -13.47M |
| Total Depreciation and Amortization | 253.20K | 246.80K | 245.20K | 239.10K | 222.10K |
| Total Amortization of Deferred Charges | 192.60K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.79M | 2.01M | 1.42M | 1.38M | 1.23M |
| Change in Net Operating Assets | -2.04M | -954.60K | -812.70K | -637.80K | -1.19M |
| Cash from Operations | -6.99M | -11.01M | -11.25M | -11.83M | -13.20M |
| Capital Expenditure | -107.50K | -120.20K | -140.90K | -265.40K | -409.70K |
| Sale of Property, Plant, and Equipment | -- | -- | 7.50K | 7.50K | 7.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 1.00M | 3.00M |
| Cash from Investing | -107.50K | -120.20K | -133.40K | 742.10K | 2.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.61M | 5.87M | 11.07M | 11.01M | 9.85M |
| Repurchase of Common Stock | -79.10K | -81.40K | -80.20K | -45.70K | -133.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.02M | 1.48M | -1.07M | -1.05M | -1.09M |
| Cash from Financing | 5.56M | 7.27M | 9.92M | 9.92M | 8.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.55M | -3.86M | -1.46M | -1.17M | -1.99M |